Jakob Dupont - Net Worth and Insider Trading
Jakob Dupont Net Worth
The estimated net worth of Jakob Dupont is at least $219,019 dollars as of 2024-04-28. Jakob Dupont is the EVP, Head of R&D of Atara Biotherapeutics Inc and owns about 290,794 shares of Atara Biotherapeutics Inc (ATRA) stock worth over $200,648. Jakob Dupont is the SVP & Chief Medical Officer of OncoMed Pharmaceuticals Inc and owns about 20,642 shares of OncoMed Pharmaceuticals Inc (OMED) stock worth over $18,371. Jakob Dupont is also the Chief Medical Officer of Gossamer Bio Inc and owns about 0 shares of Gossamer Bio Inc (GOSS) stock worth over $0. Details can be seen in Jakob Dupont's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jakob Dupont has not made any transactions after 2023-03-02 and currently still holds the listed stock(s).
Transaction Summary of Jakob Dupont
Jakob Dupont Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jakob Dupont owns 6 companies in total, including Atara Biotherapeutics Inc (ATRA) , Gossamer Bio Inc (GOSS) , and OncoMed Pharmaceuticals Inc (OMED) among others .
Click here to see the complete history of Jakob Dupont’s form 4 insider trades.
Insider Ownership Summary of Jakob Dupont
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ATRA | Atara Biotherapeutics Inc | 2023-03-02 | EVP & Head of R&D |
GOSS | Gossamer Bio Inc | 2019-12-30 | Chief Medical Officer |
OMED | OncoMed Pharmaceuticals Inc | 2016-10-09 | SVP & Chief Medical Officer |
APGN | Apexigen Inc | 2022-07-29 | director |
PYXS | Pyxis Oncology Inc | 2023-08-23 | director |
BCACU | Brookline Capital Acquisition Corp | 2022-07-29 | director |
Jakob Dupont Latest Holdings Summary
Jakob Dupont currently owns a total of 3 stocks. Among these stocks, Jakob Dupont owns 290,794 shares of Atara Biotherapeutics Inc (ATRA) as of March 2, 2023, with a value of $200,648 and a weighting of 91.61%. Jakob Dupont owns 20,642 shares of OncoMed Pharmaceuticals Inc (OMED) as of January 11, 2016, with a value of $18,371 and a weighting of 8.39%. Jakob Dupont also owns 0 shares of Gossamer Bio Inc (GOSS) as of December 30, 2019, with a value of $0 and a weighting of 0%.
Latest Holdings of Jakob Dupont
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ATRA | Atara Biotherapeutics Inc | 2023-03-02 | 290,794 | 0.69 | 200,648 |
OMED | OncoMed Pharmaceuticals Inc | 2016-01-11 | 20,642 | 0.89 | 18,371 |
GOSS | Gossamer Bio Inc | 2019-12-30 | 0 | 0.67 | 0 |
Holding Weightings of Jakob Dupont
Jakob Dupont Form 4 Trading Tracker
According to the SEC Form 4 filings, Jakob Dupont has made a total of 11 transactions in Atara Biotherapeutics Inc (ATRA) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Atara Biotherapeutics Inc is the sale of 5,074 shares on March 2, 2023, which brought Jakob Dupont around $18,419.
According to the SEC Form 4 filings, Jakob Dupont has made a total of 0 transactions in OncoMed Pharmaceuticals Inc (OMED) over the past 5 years. The most-recent trade in OncoMed Pharmaceuticals Inc is the sale of 2,500 shares on January 11, 2016, which brought Jakob Dupont around $50,025.
According to the SEC Form 4 filings, Jakob Dupont has made a total of 1 transactions in Gossamer Bio Inc (GOSS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Gossamer Bio Inc is the sale of 41,994 shares on December 30, 2019, which brought Jakob Dupont around $631,590.
Insider Trading History of Jakob Dupont
- 1
Jakob Dupont Trading Performance
Jakob Dupont Ownership Network
Ownership Network List of Jakob Dupont
Ownership Network Relation of Jakob Dupont
Jakob Dupont Owned Company Details
What does Atara Biotherapeutics Inc do?
Who are the key executives at Atara Biotherapeutics Inc?
Jakob Dupont is the EVP & Head of R&D of Atara Biotherapeutics Inc. Other key executives at Atara Biotherapeutics Inc include EVP & Global Head RA & Quality Jill Henrich , EVP & Chief Sci. & Tech Officer Anhco Nguyen , and SVP & CFO Eric J Hyllengren .
Atara Biotherapeutics Inc (ATRA) Insider Trades Summary
Over the past 18 months, Jakob Dupont made 2 insider transaction in Atara Biotherapeutics Inc (ATRA) with a net sale of 9,416. Other recent insider transactions involving Atara Biotherapeutics Inc (ATRA) include a net sale of 151,346 shares made by Pascal Touchon , a net sale of 43,245 shares made by Amar Murugan , and a net sale of 34,741 shares made by Eric J Hyllengren .
In summary, during the past 3 months, insiders sold 56,192 shares of Atara Biotherapeutics Inc (ATRA) in total and bought 0 shares, with a net sale of 56,192 shares. During the past 18 months, 337,881 shares of Atara Biotherapeutics Inc (ATRA) were sold and 816,825 shares were bought by its insiders, resulting in a net purchase of 478,944 shares.
Atara Biotherapeutics Inc (ATRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Atara Biotherapeutics Inc Insider Transactions
Jakob Dupont Mailing Address
Above is the net worth, insider trading, and ownership report for Jakob Dupont. You might contact Jakob Dupont via mailing address: C/o Oncomed Pharmaceuticals, Inc., 800 Chesapeake Drive, Redwood City Ca 94063.